Myocardial viability in ischemic heart disease: New directions and perspectives

Italian Heart Journal

Volumn 2, Issue 2, 2001, Pages 93-99

  Previtali, M ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Dobutamine echocardiography; Left ventricular dysfunction; Myocardial viability; Prognosis

Indexed keywords

DOBUTAMINE; TRACER;

ANAMNESIS; ARTICLE; CELL DIFFERENTIATION; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; GATED IMAGING; GENE EXPRESSION; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL DECISION MAKING; MYOCARDIAL HIBERNATION; NUCLEAR MEDICINE; PATHOPHYSIOLOGY; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STUNNED HEART MUSCLE; SURVIVAL; TIME; ULTRASTRUCTURE;

CARDIOTONIC AGENTS; DOBUTAMINE; EXERCISE TEST; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0035049117     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. Reversibility of cardiac wall-motion abnormalities predicted by a positron tomography
2. Improved regional ventricular function after successful surgical revascularization
3. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction: Comparison with positron emission tomography
4. Myocardial "stunning" in man
5. Current diagnostic techniques of assessing viability in patients with hibernating and stunned myocardium
6. Medical and cellular implications of stunning, hibernation and preconditioning. An NHLBI workshop
7. Myocardial perfusion-contraction matching. Implications for coronary heart disease and hibernation
8. The hibernating myocardium
9. Pathophysiology of chronic left ventricular dysfunction: New insight from the measurement of absolute myocardial blood flow and glucose utilization
10. Myocardial blood flow, glucose uptake and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction: Implications for the pathophysiology of chronic myocardial hibernation
11. Mechanisms of chronic regional postischemic dysfunction in humans: New insights from the study of noninfarcted collateral-dependent myocardium
12. Delineation of myocardial viability with PET
13. Alteration in the regulation of myocardial blood flow in one-vessel coronary artery disease determined by positron emission tomography
14. Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium)
15. Hibernating myocardium: Morphological correlates of inotropic stimulation and glucose uptake
16. Chronic myocardial hibernation in humans: From bedside to bench
17. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs: Hibernation versus stunning?
18. Immediate improvement of dysfunctional myocardial segments after coronary revascularization: Detection by intraoperative transesophageal echocardiography
19. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic artery disease
20. Effects of coronary revascularization on regional wall motion: An intraoperative two-dimensional study
21. Metabolic and functional recovery of ischemic myocardium after coronary angioplasty
22. Sequential studies of left ventricular function and wall motion after coronary bypass surgery
23. Only hibernating myocardium invariably shows early recovery after coronary revascularization
24. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in human
25. Relation between coronary artery stenosis and myocardial purine metabolism, histology and regional function in humans
26. Myocyte degeneration and cell death in hibernating human myocardium
27. Ultrastructural correlates of left ventricular contraction abnormalities in patients with chronic ischemic heart disease: Determinants of reversible segmental asynergy postrevascularization surgery
28. Structural correlates of regional myocardial dys-function in patients with critical coronary artery stenosis: Chronic hibernation?
29. Histological alterations in chronically hypoperfused myocardium: Correlation with PET findings
30. Molecular changes of titin in left ventricular dysfunction as a result of chronic hibernation
31. Chronic ischemic viable myocardium in man: Aspects of de-differentiation
32. Transgenic mouse model of stunned myocardium
33. Myocardial cell death and apoptosis in hibernating myocardium
34. Hibernating myocardium. An incomplete adaptation to ischemia
35. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose
36. Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201-TI defects
37. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99m Tc-sestamibi with thallium reinjection and 18F-fluorodeoxyglucose
38. Thallium reinjection after stress-redistribution imaging. Does 24-hour delayed imaging after reinjection enhance detection of viable myocardium?
39. Regional left ventricular wall thickening. Relation to regional uptake of 18F-fluorodeoxyglucose and 201 T1 in patients with chronic coronary artery disease and left ventricular dysfunction
40. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up
41. 18F-fluorodeoxyglucose single photon emission computed tomography. Can it replace PET and thallium SPECT for the assessment of myocardial viability?
42. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization
43. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty
44. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease
45. Relation between thallium uptake and contractile response to dobutamine. Implications regarding myocardial viability in patients with chronic coronary artery disease and left ventricular dysfunction
46. Relation of the contractile reserve of hibernating myocardium to myocardial structure in humans
47. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT. Correlation with histopathology in explanted hearts
48. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection and dobutamine echocardiography
49. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: Comparison of pooled data
50. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low-dose dobutamine echocardiography for prediction of reversibility of chronic left ischemic dysfunction
51. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201 T1 single-photon emission computed tomography
52. Dobutamine echocardiography and quantitative rest-redistribution 201 T1 tomography in myocardial hibernation. Relation of contractile reserve to 201T1 uptake and comparative prediction of recovery of function
53. Dobutamine echocardiography for determining the extent of myocardial salvage after reperfusion: An experimental evaluation
54. There may be more to myocardial viability than meets the eye!
55. Contractile reserve of dysfunctional myocardium after revascularization: A dobutamine stress echocardiography study
56. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome
57. Biphasic response to dobutamine predicts improvements of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: Implications of time course of recovery on diagnostic accuracy
58. Delayed recovery of revascularized myocardium after referral for cardiac transplantation
59. Specificity and sensitivity of exercise-induced ST-segment elevation for detection of residual viability: Comparison with fluorodeoxyglucose and positron emission tomography
60. Significance of ST-segment elevation during dobutamine-stress echocardiography in patients with acute myocardial infarction treated with thrombolysis
61. Significance of transient ST-T segment changes during dobutamine testing in Q wave myocardial infarction
62. ST-segment elevation during dobutamine stress testing predicts functional recovery after acute myocardial infarction
63. Dobutamine-induced ST-segment elevation in patients with acute myocardial infarction and the role of myocardial ischemia, viability, and ventricular dyssynergy
64. Significance of dobutamine-induced ST-segment elevation and T-wave pseudonormalization in patients with Q-wave myocardial infarction: Simultaneous evaluation by dobutamine stress echocardiography and thallium-201 SPECT
65. Value of transthoracic two-dimensional echocardiography in predicting viability in patients with healed Q-wave anterior myocardial infarction
66. End-diastolic wall thickness as a predictor of recovery of function in myocardial hibernation. Relation to rest-redistribution T1-201 tomography and dobutamine stress echocardiography
67. Postextrasystolic potentiation as a predictor of potential myocardial viability: Preoperative analysis compared with studies after coronary bypass surgery
68. Color Doppler imaging: A new technique for the assessment of myocardial function
69. Quantitative evaluation of the segmental response during dobutamine stress by tissue Doppler echocardiography
70. Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction
71. Comparison of myocardial contrast echocardiography and low-dose dobutamine stress echocardiography in predicting recovery of left ventricular function after coronary revascularization in chronic ischemic heart disease
72. Myocardial contrast echocardiography functional versus dobutamine echocardiography for predicting functional recovery after acute myocardial infarction treated with primary angioplasty
73. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction. New insights using myocardial contrast echocardiography
74. Temporal changes in myocardial perfusion patterns in patients with reperfused anterior wall myocardial infarction. Their relation to myocardial viability
75. Detection of coronary artery disease with myocardial contrast echocardiography. Comparison with 99mTc-sestamibi single-photon emission computed tomography
76. Detection of myocardial perfusion in multiple echocardiographic windows with one intravenous injection of microbubbles using transient response second harmonic imaging
77. Functional assessment with ECG-gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization
78. Effects of low-dose dobutamine on left ventricular function in normal subjects as assessed by gated single-photon emission tomography myocardial perfusion studies
79. Simultaneous assessment of myocardial viability and function for the detection of hibernating myocardium using ECG-gated 99mTc-tetrofosmin emission tomography: A comparison with 201 T1 emission tomography magnetic resonance imaging
80. 99mTc-tetrofosmin SPECT for prediction of functional recovery defined by MRI in patients with severe left ventricular dysfunction: Additional value of gated SPECT
81. Assessment of perfusion, function and myocardial metabolism after infarction with a combination of low-dose dobutamine tetrofosmin gated SPECT perfusion scintigraphy and BMIPP SPECT imaging
82. BMIPP imaging to improve the value of sestamibi scintigraphy for predicting functional outcome in severe chronic ischemic left ventricular dysfunction
83. Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis
84. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography
85. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction
86. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization
87. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine echocardiography
88. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure
89. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction
90. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy
91. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability
92. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction